Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026)
Praxis Precision Medicines (PRAX) posted quarterly Research & Development of $78.0 million for Q1 2026, up 28.26% year-over-year from $60.8 million in Q1 2025, and up 0.62% quarter-over-quarter from $77.5 million in Q4 2025.
Praxis Precision Medicines (PRAX) Research & Development (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' Research & Development history runs 8 years deep, the most recent figure standing at $78.0 million for Q1 2026.
- In Q1 2026, Research & Development rose 28.26% year-over-year to $78.0 million; the TTM figure through Mar 2026 stood at $284.3 million (up 52.65% YoY), while the FY2025 annual figure was $267.1 million, up 75.26% from the prior year.
- Research & Development for Q1 2026 stood at $78.0 million, up from $77.5 million in the prior quarter.
- The five-year high for Research & Development was $78.0 million in Q1 2026, with the low at $17.3 million in Q3 2023.
- The 5-year median for Research & Development is $41.9 million (2024), against an average of $43.5 million.
- The sharpest annual moves came in 2023 and 2024: Research & Development tumbled 51.56% in 2023, then soared 206.11% in 2024.
- Praxis Precision Medicines' Research & Development stood at $28.3 million in 2022, then plunged by 35.09% to $18.4 million in 2023, then jumped by 206.11% to $56.3 million in 2024, then jumped by 37.7% to $77.5 million in 2025, then climbed by 0.62% to $78.0 million in 2026.
- Business Quant data shows PRAX's Research & Development at $78.0 million in Q1 2026, $77.5 million in Q4 2025, and $65.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 993.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.63 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.37 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 394.92 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 612.28 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 1,146.05 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 97.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 413.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 210.03 Mn |
| 10 | Praxis Precision Medicines | 10.24 Bn | 9.48 Bn | - | 69.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 69.42 Mn |
| Mar 31, 2026 | 77.99 Mn |
| Dec 31, 2025 | 77.51 Mn |
| Sep 30, 2025 | 65.80 Mn |
| Jun 30, 2025 | 63.01 Mn |
| Mar 31, 2025 | 60.81 Mn |
| Dec 31, 2024 | 56.29 Mn |
| Sep 30, 2024 | 41.88 Mn |
| Jun 30, 2024 | 27.26 Mn |
| Mar 31, 2024 | 26.98 Mn |
| Dec 31, 2023 | 18.39 Mn |
| Sep 30, 2023 | 17.26 Mn |
| Jun 30, 2023 | 25.61 Mn |
| Mar 31, 2023 | 25.50 Mn |
| Dec 31, 2022 | 28.33 Mn |
| Sep 30, 2022 | 30.44 Mn |
| Jun 30, 2022 | 43.62 Mn |
| Mar 31, 2022 | 52.65 Mn |
| Dec 31, 2021 | 43.51 Mn |
| Sep 30, 2021 | 33.14 Mn |